TNF-Related Apoptosis-Inducing Ligand
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"TNF-Related Apoptosis-Inducing Ligand" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A transmembrane-protein belonging to the TNF family of intercellular signaling proteins. It is a widely expressed ligand that activates APOPTOSIS by binding to TNF-RELATED APOPTOSIS-INDUCING LIGAND RECEPTORS. The membrane-bound form of the protein can be cleaved by specific CYSTEINE ENDOPEPTIDASES to form a soluble ligand form.
    
			
			
				
				
					
						| Descriptor ID | D053221 | 
					
						| MeSH Number(s) | D12.644.276.374.750.625 D12.776.467.374.750.625 D23.529.374.750.625 | 
					
						| Concept/Terms | TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandApoptosis-Inducing Ligand, TNF-RelatedTNF Related Apoptosis Inducing LigandApo-2 LigandApo 2 LigandTumor Necrosis Factor Ligand Superfamily Member 10Apo-2L ProteinApo 2L ProteinTNF Superfamily, Member 10CD253 AntigenAntigen, CD253TRAIL Protein
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "TNF-Related Apoptosis-Inducing Ligand".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "TNF-Related Apoptosis-Inducing Ligand".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "TNF-Related Apoptosis-Inducing Ligand" by people in this website by year, and whether "TNF-Related Apoptosis-Inducing Ligand" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2002 | 0 | 1 | 1 | 
| 2003 | 0 | 1 | 1 | 
| 2004 | 0 | 1 | 1 | 
| 2006 | 1 | 1 | 2 | 
| 2007 | 1 | 0 | 1 | 
| 2008 | 0 | 1 | 1 | 
| 2009 | 1 | 0 | 1 | 
| 2010 | 1 | 0 | 1 | 
| 2013 | 1 | 1 | 2 | 
| 2014 | 1 | 0 | 1 | 
| 2016 | 1 | 1 | 2 | 
| 2019 | 1 | 0 | 1 | 
| 2023 | 0 | 1 | 1 | 
| 2025 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "TNF-Related Apoptosis-Inducing Ligand" by people in Profiles.
						
					
								- 
								Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism. Nat Commun. 2025 Jan 09; 16(1):533. 
- 
								An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer. Hum Mol Genet. 2023 01 01; 32(1):139-150. 
- 
								HIV elite control is associated with reduced TRAILshort expression. AIDS. 2019 09 01; 33(11):1757-1763. 
- 
								Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Hum Mol Genet. 2016 11 01; 25(21):4835-4846. 
- 
								Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. J Clin Invest. 2016 Apr 01; 126(4):1566-80. 
- 
								Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells. Mol Carcinog. 2016 Apr; 55(4):387-96. 
- 
								TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol. J Pharmacol Sci. 2015 Jan; 127(1):83-91. 
- 
								A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Dec; 12(4):248-54. 
- 
								Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther. 2014 Jan; 22(1):140-8. 
- 
								Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett. 2011 Nov 28; 310(2):148-59.